Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares gapped down prior to trading on Friday . The stock had previously closed at $7.40, but opened at $7.0801. Coloplast A/S shares last traded at $7.12, with a volume of 6,298 shares.

Analysts Set New Price Targets

Separately, Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Coloplast A/S Price Performance

The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The stock has a 50 day simple moving average of $6.56 and a 200-day simple moving average of $6.59. The firm has a market cap of $16.11 billion, a PE ratio of 37.63, a price-to-earnings-growth ratio of 2.79 and a beta of 0.16.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.10. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a return on equity of 38.81% and a net margin of 9.68%. Equities analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.